Overview: Anti-Thyroid Peroxidase Antibody TestIntroduction: The Anti-Thyroid Peroxidase Antibody Test detects antibodies to thyroid peroxidase, linked to autoimmune thyroid diseases causing fatigue or heart palpitations. Aligned with 2023 ATA guidelines, it uses an immunoassay for high sensitivity, aiding in autoimmune screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in immunology for patients with suspected thyroid autoimmune conditions.
Other Names: Anti-TPO Assay, Thyroid Peroxidase Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Thyroid antibody testing began in the 1950s with immunofluorescence. Anti-TPO assays emerged in the 1980s, and by the 2000s, immunoassays improved specificity for thyroid disorders.
Purpose: Diagnoses thyroid autoimmune disorders, guides treatment, and monitors disease activity in patients with fatigue or heart palpitations.
Test Parameters: 1. Anti Thyroid Peroxidase Antibody
Pretest Condition: Fasting for 10-12 hours required to stabilize antibody levels. Collect serum or saliva after overnight fasting. Report symptoms like fatigue or palpitations, and list medications like thyroid hormone replacement.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document thyroid symptoms, autoimmune disease history, or family history of thyroid disorders. Include current medications, especially thyroid hormone replacement.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for treatment or further testing.
Procedural Considerations: Uses an immunoassay to measure anti-TPO antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples or thyroid medications may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Positive results confirm thyroid autoimmune disorders, prompting thyroid hormone therapy or monitoring. Negative results may require anti-thyroglobulin testing.
Specialist Consultation: Consult an endocrinologist for result interpretation. A thyroid specialist referral is advised for complex cases.
Additional Supporting Tests: Anti-thyroglobulin test, TSH, or thyroid ultrasound to confirm thyroid disorders or assess gland function.
Test Limitations: False positives may occur with other autoimmune conditions. Results require clinical correlation with thyroid function tests.
References: ATA Thyroid Guidelines, 2023; Thyroid, Burman KD, 2022.
